Andrea Tanner
Primary Care · Grand Blanc, MINPI 1447842372
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 30.1% of the total.
Across 188 payments — averaging $11.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$671
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$520
- Alkermes, Inc.$300
- Vanda Pharmaceuticals Inc.$188
- Neurocrine Biosciences, Inc.$151
- Otsuka America Pharmaceutical, Inc.$68
- plus $330 from 12 others
What the payments were for
- Food & beverage$2,18098%
- Education$492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 84 | $671 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 49 | $520 |
| Alkermes, Inc. | 17 | $300 |
| Vanda Pharmaceuticals Inc. | 10 | $188 |
| Neurocrine Biosciences, Inc. | 7 | $151 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Novo Nordisk | 2 | $45 |
| Exact Sciences | 2 | $36 |
| Lilly USA, LLC | 2 | $32 |
| Medtronic | 1 | $26 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Novartis | 1 | $16 |
How this compares
$2,229 in reported general payments places this provider in the 85th percentile of 292 primary care providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 23 | $21,789 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $6,794 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 48 | $1,713 |
| Atorvastatin Calcium | 57 | $986 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 13 | $771 |
| Amlodipine Besylate | 61 | $664 |
| Ventolin HfaAlbuterol Sulfate | 11 | $528 |
| Gabapentin | 41 | $507 |
| Omeprazole | 40 | $490 |
| Lisinopril | 37 | $431 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 15 | $429 |
| Levothyroxine Sodium | 24 | $305 |
| Hydralazine Hcl | 14 | $298 |
| Metoprolol Succinate | 16 | $288 |
| Losartan Potassium | 16 | $268 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $45 | $21,78923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 292 primary care providers in Michigan.
Other primary care in Grand Blanc
- Donna HamillGrosse Pointe$17K
- Marie Sighe-NzokouLansing$16K
- Alexandria SchwabBay City$10K
- Amy HenryRochester Hills$10K
- Claire GebaraWaterford$9K
- Vanita RobinsonDetroit$9K
- Mary BoudreauMason$9K
- Kimberly FrazierLansing$8K
- Rachel HetznerMadison Heights$8K
- Katherine HouleMarquette$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.